During the past decade, Infectious Diseases Institute Kasangati conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Infectious Diseases Institute Kasangati" #1 collaborator was "Massachusetts General Hospital" with 3 trials as a collaborator, "Harvard Medical School (HMS and HSDM)" with 2 trials as a collaborator, "University of Washington" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Fred Hutchinson Cancer Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Infectious Diseases Institute Kasangati" are "HIV" (3 trials), "PrEP" (3 trials), "Sexually Transmitted Infections" (2 trials), "Transgender Women" (2 trials) and "HIV-1-infection" (1 trials). Many other conditions were trialed in "Infectious Diseases Institute Kasangati" in a lesser frequency.

Most popular intervention types in "Infectious Diseases Institute Kasangati" are "Biological" (1 trials), "Combination Product" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "10-1074-LS-J" (1 trials), "3BNC117-LS-J" (1 trials), "Combination 3BNC117-LS-J and 10-1074-LS-J" (1 trials), "Combination 3BNC117-LS-J and 10-1074-LS-J Ratio 1" (1 trials) and "Combination 3BNC117-LS-J and 10-1074-LS-J Ratio 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Infectious Diseases Institute Kasangati" are 2 trials for "Male" genders, 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Infectious Diseases Institute Kasangati". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Infectious Diseases Institute Kasangati, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Infectious Diseases Institute Kasangati, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".